Prosecution Insights
Last updated: September 17, 2026
Application No. 18/875,180

TPE PACIFIER

Non-Final OA §102§112
Filed
Dec 16, 2024
Priority
Jun 15, 2022 — DK PA202200576 +2 more
Examiner
HOLLM, JONATHAN ADAM
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Niels Peter Estrup
OA Round
1 (Non-Final)
50%
Grant Probability
Moderate
1-2
OA Rounds
2y 6m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allowance Rate
271 granted / 540 resolved
-19.8% vs TC avg
Strong +53% interview lift
Without
With
+53.3%
Interview Lift
resolved cases with interview
Typical timeline
4y 3m
Avg Prosecution
24 currently pending
Career history
569
Total Applications
across all art units

Statute-Specific Performance

§101
2.9%
-37.1% vs TC avg
§103
49.8%
+9.8% vs TC avg
§102
17.8%
-22.2% vs TC avg
§112
24.6%
-15.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 540 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Priority Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Information Disclosure Statement The information disclosure statement (IDS) submitted on December 16, 2024 is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner. Specification 37 C.F.R. § 1.74 requires that “[w]hen there are drawings, there shall be a brief description of the several views of the drawings and the detailed description of the invention shall refer to the different views by specifying the numbers of the figures, and to the different parts by use of reference letters or numerals (preferably the latter). The Specification is objected to under 37 C.F.R. § 1.74 as lacking a brief description of and a detailed description of Figs. 1-10 of the drawings. Claim Objections MPEP § 608.01(m) states that “[e]ach claim begins with a capital letter and ends with a period. Periods may not be used elsewhere in the claims except for abbreviations.” Claims 1 and 7 are objected to because they include intervening periods (“.”). In claim 1, multiple periods (“.”) appear throughout the claim that should be a comma (“,”), semicolon (“;”), or other punctuation so that the claim is a single sentence. In claim 7, a period (“.”) appears in line 3 before the end of the claim that should be a comma (“,”), semicolon (“;”), or other punctuation so that the claim is a single sentence. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-8 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 includes multiple sentences with apparently conflicting limitations that render the claim indefinite. First, claim 1 recites the pacifier is made “in a one-piece or in several parts” in lines 2-3, but later recites the pacifier is “2-componenet injection molded pacifier . . . where the nipple (2, 3) is molded onto the shield (1) wherein the shield (1) is in two-piece or in several parts” in lines 10-13. A person having ordinary skill in the art would find the metes and bounds of claim 1 to be unclear because the claim is unclear as to how many pieces are in the pacifier construction. Second, claim 1 recites pacifier including “a hole (8) going inside the pacifier on the back side of the shield (1) allowing air into the inside of the nipple (14, 2,3)” in lines 6-8, but later recites “the shield (1) has a closed backside (4, 5, 6) and an airtight nipple (14)” in lines 14-15. A person having ordinary skill in the art would find the metes and bounds of claim 1 to be unclear because the claim is unclear as to whether the pacifier allows air into the nipple or is closed airtight (i.e., not allowing air into the nipple). The conflicting recitations, as explained above, create a great deal of confusion and uncertainty as to the proper interpretation of claim 1, thus the metes and bounds of claim 1 are unclear and claim 1 is indefinite. Claims 2 and 4-8 are rejected as being dependent upon rejected claim 1. Claim 3 recites the pacifier made with different materials “if needed” in line 4. Such language renders claim 3 indefinite because the claim is unclear as to whether the claimed pacifier requires different materials. Claim 6 recites the pacifier can change color when temperature is 37 degrees or lower “if preferred” in lines 3-4. Such language renders claim 6 indefinite because the claim is unclear as to what temperature the pacifier can change color. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim 3 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Schofield et al. (U.S. Patent No. 9095501; hereinafter “Schofield”). Regarding claim 3, Schofield discloses a TPE pacifier (Figs. 2a-15; col. 7, ll. 1-5) that can also be injected molded in more than two pieces up to 3 or 6 parts could be made into one mold (the pacifier of Schofield can be (i.e., is capable of being) injected molded in more than two pieces because multiple components of the pacifier are injection molded together and no structure in Schofield would prevent more than two pieces to be injection molded together), so the pacifier could have more than 6 different materials molded together and made into one pacifier in the same injection tool and at the same time, but made with different materials if needed (col. 3, ll. 52-59; col. 4, ln. 47 – col. 5, ln. 32). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: Evans et al. (U.S. Patent Application Publication No. 20190290548) disclosing an ant-bacterial, scent-carrying pacifier; Hakim (U.S. Patent No. 4143452) disclosing pacifiers having open or closed backsides; Gu (U.S. Patent Application Publication No. 20040220323) disclosing a recyclable thermoplastic elastomer suitable for nipples and teething rings; Rohrig (U.S. Patent Application Publication No. 20090249571) disclosing a multi-component injection molded teething device; and Ford et al. (U.S. Patent Application Publication No. 20150272447) disclosing a pacifier having materials that change color based on a user’s temperature to indicate the presence of a fever. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Jonathan A Hollm whose telephone number is (703)756-1514. The examiner can normally be reached Mon - Fri 8:30-5:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Elizabeth Houston can be reached at (571) 272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JONATHAN A HOLLM/Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Dec 16, 2024
Application Filed
Jun 29, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12733916
MODULAR FORCEPS
3y 3m to grant Granted Sep 15, 2026
Patent 12727877
SURGICAL SUTURE TENSIONING AND LABELING
4y 3m to grant Granted Sep 08, 2026
Patent 12728248
DEVICES AND METHODS FOR COSMETIC SKIN RESURFACING
4y 0m to grant Granted Sep 08, 2026
Patent 12721622
MEDICAL SUTURE NEEDLE
4y 8m to grant Granted Sep 01, 2026
Patent 12708387
INTRALUMINAL DEVICE WITH VARIABLE WIRE CONFIGURATION
5y 6m to grant Granted Aug 18, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
50%
Grant Probability
99%
With Interview (+53.3%)
4y 3m (~2y 6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 540 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month